T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
HealthStream
HSTM
$849M
| $474K | ﹤0.01% |
16,975
+797
| +5% | +$21.2K |
|
2202
Stoke Therapeutics
STOK
$2.02B
| $474K | ﹤0.01% |
35,046
+3,615
| +12% | +$48.8K |
|
|
ZEUS
2203
DELISTED
Olympic Steel
ZEUS
| $474K | ﹤0.01% |
10,565
+662
| +7% | +$37.8K |
|
2204
Vaalco Energy
EGY
$592M
| $472K | ﹤0.01% |
75,217
+9,539
| +15% | +$61.5K |
|
2205
Hain Celestial
HAIN
$53.9M
| $471K | ﹤0.01% |
68,100
+7,933
| +13% | +$54.5K |
|
2206
IDT Corp
IDT
$1.67B
| $471K | ﹤0.01% |
13,089
+442
| +3% | +$16.6K |
|
|
UNIT
2207
Uniti Group
UNIT
$2.38B
| $470K | ﹤0.01% |
160,694
+7,017
| +5% | +$29.4K |
|
|
NVRO
2208
DELISTED
NEVRO CORP.
NVRO
| $469K | ﹤0.01% |
55,655
+10,639
| +24% | +$113K |
|
2209
CareDx
CDNA
$2.45B
| $468K | ﹤0.01% |
30,131
+735
| +3% | +$8.88K |
|
2210
Compass Diversified
CODI
$924M
| $464K | ﹤0.01% |
21,190
+3,139
| +17% | +$70.6K |
|
2211
Revolve Group
RVLV
$1.72B
| $464K | ﹤0.01% |
29,142
+2,644
| +10% | +$50.6K |
|
2212
B&G Foods
BGS
$299M
| $463K | ﹤0.01% |
57,251
+2,389
| +4% | +$23.6K |
|
2213
Manitowoc
MTW
$753M
| $463K | ﹤0.01% |
40,097
+287
| +0.7% | +$3.55K |
|
2214
NETGEAR
NTGR
$647M
| $463K | ﹤0.01% |
30,227
-7,552
| -20% | -$106K |
|
2215
Clear Channel Outdoor Holdings
CCO
$1.18B
| $458K | ﹤0.01% |
323,927
+1,327
| +0.4% | +$1.96K |
|
2216
Green Dot
GDOT
$770M
| $456K | ﹤0.01% |
48,181
+2,752
| +6% | +$25.6K |
|
2217
Energy Recovery
ERII
$399M
| $454K | ﹤0.01% |
34,128
+4,372
| +15% | +$60.3K |
|
2218
Castle Biosciences
CSTL
$933M
| $450K | ﹤0.01% |
20,648
+2,614
| +14% | +$58.3K |
|
2219
Movado Group
MOV
$796M
| $450K | ﹤0.01% |
18,066
+347
| +2% | +$9.07K |
|
2220
NWPX Infrastructure Inc
NWPX
$1.11B
| $450K | ﹤0.01% |
13,236
-73
| -0.5% | -$2.48K |
|
2221
Sinclair Inc
SBGI
$1.03B
| $450K | ﹤0.01% |
33,690
-81,174
| -71% | -$1.04M |
|
2222
Red Robin
RRGB
$183M
| $449K | ﹤0.01% |
59,290
-60,051
| -50% | -$437K |
|
|
DHC
2223
Diversified Healthcare Trust
DHC
$2.03B
| $448K | ﹤0.01% |
146,598
+3,585
| +3% | +$9.1K |
|
|
ADAM
2224
Adamas Trust
ADAM
$907M
| $447K | ﹤0.01% |
76,396
+2,679
| +4% | +$17.2K |
|
2225
Perdoceo Education
PRDO
$1.99B
| $447K | ﹤0.01% |
20,833
+2,153
| +12% | +$44.6K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.